147 related articles for article (PubMed ID: 35658790)
1. An ultra-sensitive method to detect mutations in human
Li S; Counter CM
Small GTPases; 2022 Jan; 13(1):287-295. PubMed ID: 35658790
[TBL] [Abstract][Full Text] [Related]
2. Reduced HRAS G12V-Driven Tumorigenesis of Cell Lines Expressing KRAS C118S.
Huang L; Counter CM
PLoS One; 2015; 10(4):e0123918. PubMed ID: 25902334
[TBL] [Abstract][Full Text] [Related]
3. Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis.
To MD; Rosario RD; Westcott PM; Banta KL; Balmain A
Oncogene; 2013 Aug; 32(34):4028-33. PubMed ID: 22945650
[TBL] [Abstract][Full Text] [Related]
4. The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.
Westcott PM; Halliwill KD; To MD; Rashid M; Rust AG; Keane TM; Delrosario R; Jen KY; Gurley KE; Kemp CJ; Fredlund E; Quigley DA; Adams DJ; Balmain A
Nature; 2015 Jan; 517(7535):489-92. PubMed ID: 25363767
[TBL] [Abstract][Full Text] [Related]
5. Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesis.
Le Roux Ö; Pershing NLK; Kaltenbrun E; Newman NJ; Everitt JI; Baldelli E; Pierobon M; Petricoin EF; Counter CM
Elife; 2022 Sep; 11():. PubMed ID: 36069770
[TBL] [Abstract][Full Text] [Related]
6. Signaling levels mold the RAS mutation tropism of urethane.
Li S; Counter CM
Elife; 2021 May; 10():. PubMed ID: 33998997
[TBL] [Abstract][Full Text] [Related]
7. Multiplexed screens identify RAS paralogues HRAS and NRAS as suppressors of KRAS-driven lung cancer growth.
Tang R; Shuldiner EG; Kelly M; Murray CW; Hebert JD; Andrejka L; Tsai MK; Hughes NW; Parker MI; Cai H; Li YC; Wahl GM; Dunbrack RL; Jackson PK; Petrov DA; Winslow MM
Nat Cell Biol; 2023 Jan; 25(1):159-169. PubMed ID: 36635501
[TBL] [Abstract][Full Text] [Related]
8. A model for RAS mutation patterns in cancers: finding the sweet spot.
Li S; Balmain A; Counter CM
Nat Rev Cancer; 2018 Dec; 18(12):767-777. PubMed ID: 30420765
[TBL] [Abstract][Full Text] [Related]
9. RAS and RHO family GTPase mutations in cancer: twin sons of different mothers?
Hodge RG; Schaefer A; Howard SV; Der CJ
Crit Rev Biochem Mol Biol; 2020 Aug; 55(4):386-407. PubMed ID: 32838579
[TBL] [Abstract][Full Text] [Related]
10. Capturing the primordial Kras mutation initiating urethane carcinogenesis.
Li S; MacAlpine DM; Counter CM
Nat Commun; 2020 Apr; 11(1):1800. PubMed ID: 32286309
[TBL] [Abstract][Full Text] [Related]
11. Rare codons regulate KRas oncogenesis.
Lampson BL; Pershing NL; Prinz JA; Lacsina JR; Marzluff WF; Nicchitta CV; MacAlpine DM; Counter CM
Curr Biol; 2013 Jan; 23(1):70-5. PubMed ID: 23246410
[TBL] [Abstract][Full Text] [Related]
12. Non-canonical genomic driver mutations of urethane carcinogenesis.
Li S; Counter CM
PLoS One; 2022; 17(4):e0267147. PubMed ID: 35482806
[TBL] [Abstract][Full Text] [Related]
13. Kirsten Ras* oncogene: significance of its discovery in human cancer research.
Tsuchida N; Murugan AK; Grieco M
Oncotarget; 2016 Jul; 7(29):46717-46733. PubMed ID: 27102293
[TBL] [Abstract][Full Text] [Related]
14. Decreased tumorigenesis in mice with a Kras point mutation at C118.
Huang L; Carney J; Cardona DM; Counter CM
Nat Commun; 2014 Nov; 5():5410. PubMed ID: 25394415
[TBL] [Abstract][Full Text] [Related]
15. Cell-type specific tumorigenesis with Ras oncogenes in human lung epithelial cells.
Kumazaki M; Shimomura I; Kiyono T; Ochiya T; Yamamoto Y
Biochem Biophys Res Commun; 2020 Apr; 525(2):483-490. PubMed ID: 32111352
[TBL] [Abstract][Full Text] [Related]
16. Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice.
Weyandt JD; Carney JM; Pavlisko EN; Xu M; Counter CM
PLoS One; 2016; 11(12):e0167205. PubMed ID: 27911940
[TBL] [Abstract][Full Text] [Related]
17. The Abundance of KRAS and RAS Gene Mutations in Cancer.
Stites EC
Methods Mol Biol; 2024; 2797():13-22. PubMed ID: 38570449
[TBL] [Abstract][Full Text] [Related]
18. KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo.
Najumudeen AK; Fey SK; Millett LM; Ford CA; Gilroy K; Gunduz N; Ridgway RA; Anderson E; Strathdee D; Clark W; Nixon C; Morton JP; Campbell AD; Sansom OJ
Nat Commun; 2024 Jan; 15(1):100. PubMed ID: 38168062
[TBL] [Abstract][Full Text] [Related]
19. The pro-apoptotic K-Ras 4A proto-oncoprotein does not affect tumorigenesis in the ApcMin/+ mouse small intestine.
Patek CE; Arends MJ; Rose L; Luo F; Walker M; Devenney PS; Berry RL; Lawrence NJ; Ridgway RA; Sansom OJ; Hooper ML
BMC Gastroenterol; 2008 Jun; 8():24. PubMed ID: 18554389
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population.
Schulten HJ; Salama S; Al-Ahmadi A; Al-Mansouri Z; Mirza Z; Al-Ghamdi K; Al-Hamour OA; Huwait E; Gari M; Al-Qahtani MH; Al-Maghrabi J
Anticancer Res; 2013 Nov; 33(11):4779-84. PubMed ID: 24222113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
